GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Schott Pharma AG & CO KGaA (CHIX:1SXPd) » Definitions » Other Long Term Assets

Schott Pharma AG KGaA (CHIX:1SXPD) Other Long Term Assets : €109.1 Mil (As of Dec. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Schott Pharma AG KGaA Other Long Term Assets?

Schott Pharma AG KGaA's other long-term assets for the quarter that ended in Dec. 2024 was €109.1 Mil.

Schott Pharma AG KGaA's quarterly other long-term assets declined from Jun. 2024 (€102.8 Mil) to Sep. 2024 (€99.7 Mil) but then increased from Sep. 2024 (€99.7 Mil) to Dec. 2024 (€109.1 Mil).

Schott Pharma AG KGaA's annual other long-term assets increased from Sep. 2022 (€91.9 Mil) to Sep. 2023 (€94.7 Mil) and increased from Sep. 2023 (€94.7 Mil) to Sep. 2024 (€99.7 Mil).


Schott Pharma AG KGaA Other Long Term Assets Historical Data

The historical data trend for Schott Pharma AG KGaA's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Schott Pharma AG KGaA Other Long Term Assets Chart

Schott Pharma AG KGaA Annual Data
Trend Sep20 Sep21 Sep22 Sep23 Sep24
Other Long Term Assets
59.04 72.55 91.90 94.74 99.71

Schott Pharma AG KGaA Quarterly Data
Sep20 Sep21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 92.09 97.96 102.78 99.71 109.09

Schott Pharma AG KGaA Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.


Schott Pharma AG KGaA Business Description

Traded in Other Exchanges
Address
Hattenbergstrasse 10, Mainz, RP, DEU, 55122
Schott Pharma AG & CO KGaA caters to the pharma, biotech and life science industry by providing containment solutions and delivery systems for injectable drugs. Its segments include; Drug Containment Solutions (DCS) and Drug Delivery Systems (DDS). The majority of the revenue is generated from Drug Containment Solutions segment which includes products like vials, cartridges and ampoules for safe drug containment. Geographically, the company generates revenue from Europe, Middle East, Africa (EMEA), Asia and South Pacific, North America and South America.

Schott Pharma AG KGaA Headlines

No Headlines